Gilead Sciences Inc (NASDAQ:GILD)

64.11
Delayed Data
As of Aug 19
 +0.97 / +1.54%
Today’s Change
60.32
Today|||52-Week Range
79.61
+2.49%
Year-to-Date

Today’s Trading

Previous close63.14
Today’s open63.69
Day’s range63.69 - 64.42
Volume6,163,388
Average volume (3 months)6,474,199
Market cap$80.1B
Data as of 4:15pm ET, 08/19/2019

Growth & Valuation

Earnings growth (last year)+18.72%
Earnings growth (this year)+4.98%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)-15.00%
P/E ratio13.8
Price/Sales3.68
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+4.04+1.74%
ILMNIllumina Inc+2.48+0.87%
AMGNAmgen+1.98+0.97%
EXASExact Sciences Corp-1.66-1.39%
Data as of 4:00pm ET, 08/19/2019

Financials

Next reporting dateOctober 29, 2019
EPS forecast (this quarter)$1.75
Annual revenue (last year)$22.2B
Annual profit (last year)$5.5B
Net profit margin24.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Daniel O'Day
CFO, Chief Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts